Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05131308 · ClinicalTrials.gov registry record

Multimodality Evaluation of LAA Leaks Arising After Incomplete LAAC: Insights From the LAA-Leak Registry

A clinical trial, sponsored by Kansas City Heart Rhythm Research Foundation.

Completed
Registry status
160
Enrollment target

NCT05131308 is a clinical trial that has completed, run by Kansas City Heart Rhythm Research Foundation. The registered enrollment target is 160 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05131308 has completed, sponsored by Kansas City Heart Rhythm Research Foundation.

COMPLETED
Registry status
160 participants
Enrollment target

Study Summary

Closure of peri-device leaks (PDL) after incomplete LAAC have shown early feasibility, however no comparison study of all the leak closure modalities exists. Therefore, this is an attempt to report the first 3-way observational comparison study to date, with results in 160 total patients in 3 arms including detachable embolization coils, vascular plugs/septal occluders and Radiofrequency ablation.

Interventions

  • OTHER leak closure with either detachable embolization coils, vascular plugs/CSO, or RFA

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2015-01-11
Est. Completion 2021-06-08

What the Registry Record Tells You About NCT05131308

The ClinicalTrials.gov registry entry for NCT05131308 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kansas City Heart Rhythm Research Foundation, which has 22 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which leak closure with either detachable embolization coils, vascular plugs/CSO, or RFA is the first listed.

NCT05131308 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05131308 about?

NCT05131308 is a clinical study titled "Multimodality Evaluation of LAA Leaks Arising After Incomplete LAAC: Insights From the LAA-Leak Registry". Closure of peri-device leaks (PDL) after incomplete LAAC have shown early feasibility, however no comparison study of all the leak closure modalities exists. Therefore, this is an attempt to report the first 3-way observational comparison study to date, with results in 160 total patients in 3 arms i...

What is the current status of trial NCT05131308?

This trial is currently completed. The enrollment target is 160 participants. The study started on 2015-01-11. Estimated completion is 2021-06-08.

What interventions are being tested in trial NCT05131308?

The interventions under investigation include: leak closure with either detachable embolization coils, vascular plugs/CSO, or RFA (OTHER).

Who is sponsoring clinical trial NCT05131308?

This trial is sponsored by Kansas City Heart Rhythm Research Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.